To build a prognostic score model containing indispensible tumour markers for metastatic nasopharyngeal carcinoma in an epidemic area
- 26 October 2011
- journal article
- Published by Elsevier BV in European Journal of Cancer
- Vol. 48 (6), 882-888
- https://doi.org/10.1016/j.ejca.2011.09.004
Abstract
No abstract availableFunding Information
- National-Eleventh Five Technology Major Project (2008ZX09312-002)
- Research Award Fund for Outstanding Young Researchers
This publication has 22 references indexed in Scilit:
- Plasma EBV DNA Clearance Rate as a Novel Prognostic Marker for Metastatic/Recurrent Nasopharyngeal CarcinomaClinical Cancer Research, 2010
- Distant Metastasis of Undifferentiated Carcinoma of Nasopharyngeal TypeOncology Research and Treatment, 2008
- Comparison of the prognostic impact of serum anti-EBV antibody and plasma EBV DNA assays in nasopharyngeal carcinomaInternational Journal of Radiation Oncology*Biology*Physics, 2007
- The Enigmatic Epidemiology of Nasopharyngeal CarcinomaCancer Epidemiology, Biomarkers & Prevention, 2006
- Nasopharyngeal carcinoma metastasis to the pituitary gland: a case report and literature review.Journal of Neuro-Oncology, 2004
- Prognostic Factors Affecting the Outcome of Nasopharyngeal CarcinomaJapanese Journal of Clinical Oncology, 2003
- Epidemiology of nasopharyngeal carcinomaSeminars in Cancer Biology, 2002
- Distant Metastases from Nasopharyngeal CancerORL, 2001
- EBV and nasopharyngeal carcinomaThe Lancet, 1994
- Histopathology of nasopharyngeal carcinoma.Correlations with epidemiology, survival rates and other biological characteristicsCancer, 1979